1,4-Bis(benzimidazol-2-yl)butane

CL Chen,CY Su,AW Xu,HX Zhang,XL Feng,BS Kang

DOI: https://doi.org/10.1107/s1600536802012904

2002-01-01

Abstract:The title compound, C18H18N4, lies on an inversion center. The benzimidazolyl moiety is essentially planar. Intermolecular N-H...N hydrogen bonds give rise to an infinite helical chain structure, with the chains stacked by C-H...pi and pi...pi interactions.

What problem does this paper attempt to address?

1,3-Bis(1h-benzimidazol-2-yl)-2-oxa-propane

Ying Chen,Jixi Guo,Ruirui Yun,Huilu Wu

DOI: https://doi.org/10.1107/s1600536809011507

2009-01-01

Abstract:The title molecule, C(16)H(14)N(4)O, lies on a crystallographic inversion center. The -CH(2)- groups and the O atom are disordered over two sites with equal occupancy, the disorder of the O atom being symmetry imposed. In the crystal structure, mol-ecules are linked into a two-dimensional network parallel to (001) via inter-molecular N-H⋯N hydrogen bonds.
1,4-Bis(2-mercaptobenzothiazolyl)butane

CL Chen,CY Su,HX Zhang,AW Xu,BS Kang

DOI: https://doi.org/10.1107/s1600536803005452

2003-01-01

Abstract:The molecular structure of the title compound, C18H16N2S4, has a center of symmetry. All the C and S atoms in the central alkyl chain are coplanar, and this plane is almost perpendicular to the benzothiazolyl rings. The molecules are linked together by intermolecular S⋯S interactions to form a one-dimensional chain.
Imidazolium 2,4-Dihydroxybenzoate

DD Lin,JG Liu,DJ Xu

DOI: https://doi.org/10.1107/s1600536805043035

2006-01-01

Abstract:The title compound, C3H5N2+center dot C7H5O4-, consists of imidazolium cations and 2,4-dihydroxybenzoate anions that link to each other via hydrogen bonding. Furthermore, pi-pi stacking is observed between parallel benzene rings and between benzene and imidazole rings.
1,4-Bis(4-methoxyphenyl)buta-1,3-diyne

Neng-Fang She,Hui-Zhen Guo,Li-Ping Cao,Meng Gao

DOI: https://doi.org/10.1107/s1600536806041535

2006-01-01

Abstract:In the structure of the title compound, C18H14O2, the two benzene rings are inclined at an angle of 54.25 (13)degrees. The packing of the molecules is mainly governed by weak intermolecular C-H center dot center dot center dot O hydrogen bonds with no pi-pi stacking observed.
1,4-Bis{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}butane

Qing-lei Liu,Wei Wang,Yan Gao,Xiao-yu Jia,Jing-jing Zhang

DOI: https://doi.org/10.1107/s1600536811006805

2011-01-01

Abstract:In the centrosymmetric title compound, C18H16N6O2S2, the 1,3,4-oxadiazole and the attached pyridinyl ring are twisted by 5.3 (3)degrees
1,3-Bis(4-tert-butylphenyl)-4-nitrobutan-1-one

Dong-Yin Ren,Lu Shi,Qin Zhang,Yi Xu,Hong-Jun Zhu

DOI: https://doi.org/10.1107/s1600536811018277

2011-01-01

Acta Crystallographica Section E Structure Reports Online

Abstract:In the crystal structure of the title compound, C(24)H(31)NO(3), mol-ecules are connected via C-H⋯O inter-molecular hydrogen bonds, forming dimers. The benzene rings are oriented at a dihedral angle of 29.8 (1)°.
1,4-Bis(1h-benzotriazol-1-ylmethyl)benzene Tetrahydrate

YP Cai,GB Li,GP He,CY Su,AW Xu,C Zhang

DOI: https://doi.org/10.1107/s1600536804026157

2004-01-01

Abstract:Molecules of the title compound, C(20)H(16)N(6.)4H(2)O, lie across crystallographic inversion centres. The dihedral angle between each benzotriazole moiety and the central benzene ring is 74.95 (9)degrees. In the crystal structure, the molecular organization is stabilized by well defined weak C-H...pi, pi-pi, O-H...O and O-H...N intermolecular interactions, leading to the formation of a two-dimensional network.
N&#8242;-[1-(4-Chlorophenyl)ethylidene]benzohydrazide

Suyuan Zeng,Lei Li

DOI: https://doi.org/10.1107/S1600536811042887

2011-01-01

Abstract:In the title molecule, C15H13ClN2O, the two benzene rings form a dihedral angle of 5.48 (4)°. In the crystal, N—H...O hydrogen bonds link molecules related by translation along the a axis into chains, which are further aggregated into layers parallel to the ac plane through weak C—H...O and C—H...N interactions.
(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Jian Zhao,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536810017010

2010-01-01

Abstract:The title compound, C(28)H(26)N(2)O(4), crystallizes as a racemate with four stereogenic centers. In the molecule, the pyrrolidone ring adopts an envelope conformation and the cyclohexene ring has a twisted envelope conformation. In the crystal structure, molecules are linked by weak intermolecular C-H center dot center dot center dot O hydrogen bonds.
4-[4-Dimethylamino-1-(4-fluorophenyl)-1-hydroxy-butyl]-3-(hydroxymethyl) Benzonitrile

JM Gu,YW Wang,XR Hu

DOI: https://doi.org/10.1107/s1600536805023032

2005-01-01

Abstract:In the structure of the title compound, C20H23FN2O2, there are two independent molecules showing different conformations. The molecules form centrosymmetric dimers via O - H (. . .) N or O - H (. . .) O hydrogen bonds.
Exo-4-[(1H-Benzimidazol-2-yl)methyl]-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

Shikun Li,Fan Zhang,TianXi Lv,Qiuyue Lin

DOI: https://doi.org/10.1107/S1600536811026602

2011-01-01

Abstract:In the title compound, C 16H 15N 3O 3, the dihedral angle between the approximately planar benzimidazolyl group (r.m.s. deviation = 0.010 Å) and the pyrrolidine ring is 78.20 (6)°. The C - C - N bond angle of the bridging CH 2 group is 112.14 (16)°. In the crystal, molecules are linked via N - H⋯N hydrogen bonds, forming infinite chains parallel to [101] and [101̄ ].
(E)-2-[2-(4-fluoro-benzyl-idene)hydrazinocarbon-yl]-n-isopropyl-benzamide.

Ming Liu,Yousheng Duan,Yi Wang,Wen-Xiong Zhang,Shangzhong Liu

DOI: https://doi.org/10.1107/s1600536809022181

2009-01-01

Abstract:The title compound, C(18)H(18)FN(3)O(2), adopts a trans conformation with respect to the C=N double bond. The dihedral angle between the two benzene rings is: 59.73 (6)°. Two independent N-H⋯O hydrogen bonds link the mol-ecules into layers parallel to (101).
(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1H-2,3-benzoxazin-4-one

Yan Wang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536809044195

2009-01-01

Abstract:In the title compound, C28H27NO2, the oxazinone ring adopts a twist-boat conformation and the cyclohexene ring has a twisted envelope conformation. The crystal structure is stabilized by weak non-classical intermolecular C—H...O hydrogen bonds.
1-(6-Chloropyridin-3-ylmethyl)-1H-benzimidazole

MingYi Cai,Zhong Li,Gonghua Song,Tao Yu,Yingli Wu

DOI: https://doi.org/10.1107/S1600536806017909

2006-01-01

Abstract:In the title compound, C13H10ClN3, the benzimidazole and chloropyridyl groups are planar and make a dihedral angle of 68.01(18)°. There are two weak C - H⋯N hydrogen bonds, producing sheets parallel to (100). © 2006 International Union of Crystallography. All rights reserved.
1,4-Bis(benzyloxy)-2-tert-butylbenzene

Guo-wei Wang,Wen-yuan Wu,Ling-hua Zhuang,Jin-tang Wang

DOI: https://doi.org/10.1107/s1600536808003383

2008-01-01

Abstract:The title compound, C(24)H(26)O(2), was obtained unintentionally as the product of an attempted synthesis of a new chiral cobalt salen catalyst. There are no classical hydrogen bonds; inter-molecular C-H⋯π stacking inter-actions between aromatic rings help to establish the mol-ecular conformation.
exo-4-[(1H-Benzimidazol-2-yl)meth-yl]-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

Shi-Kun Li,Fan Zhang,Tianxi Lv,Qiu-Yue Lin

DOI: https://doi.org/10.1107/s1600536811026602

2011-01-01

Abstract:In the title compound, C16H15N3O3, the dihedral angle between the approximately planar benzimidazolyl group (r.m.s. deviation = 0.010 A) and the pyrrolidine ring is 78.20 (6)°. The C—C—N bond angle of the bridging CH2 group is 112.14 (16)°. In the crystal, molecules are linked via N—H⋯N hydrogen bonds, forming infinite chains parallel to [101] and [10\overline{1}].
7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

Sz Jian,M Lei

DOI: https://doi.org/10.1107/S160053680502845X

2005-01-01

Abstract:In the title compound, C20H21NO3, the dihedral angle between the two benzene rings is 8.79 ( 7)degrees and the cyclohexane ring adopts a chair conformation. The molecules are linked by paired N-H O-... hydrogen bonds into centrosymmetric R-2(2)(8) dimers.
3-(Biphenyl-1-yl)-1-(4-tert-butylphenyl)-3-hydroxyprop-2-en-1-one

Chun-Yang Zheng,Jing Zheng,Dun-Jia Wang

DOI: https://doi.org/10.1107/s1600536807031133

2007-01-01

Abstract:In the title compound, C25H24O2, the molecular structure exists in a cis-enol form which is stabilized by an intramolecular O-H center dot center dot center dot O hydrogen bond. This hydrogen bond is described as an approximately symmetrical hydrogen bond. The three methyl groups are disordered over two positions, with a site occupancy ratio of ca 4:1.
1,2,4,5-Tetrakis(bromomethyl)benzene

Zhi-Guo Wang,Yu-Zhou Wang,Neng-Fang She,Meng Gao

DOI: https://doi.org/10.1107/s1600536806042334

2006-01-01

Abstract:The title molecule, C10H10Br4, lies on a crystallographic inversion center which is located at the center of the benzene ring. The crystal structure is stabilized by intermolecular Br center dot center dot center dot Br and C-H center dot center dot center dot Br interactions.
5,7-Bis(benzyloxy)-4h-benzopyran-4-one

ZF Hao,Q Xu,ZF Lu,JX Li

DOI: https://doi.org/10.1107/s1600536806000614

2006-01-01

Abstract:The title compound, C23H18O4, contains two molecules in the asymmetric unit which differ from each other in the dihedral angles between the benzyl and chromone groups. There are intramolecular and intermolecular C - H center dot center dot center dot O interactions as well as pi-pi stacking interactions in the crystal structure.

1,4-Bis(benzimidazol-2-yl)butane

1,3-Bis(1h-benzimidazol-2-yl)-2-oxa-propane

1,4-Bis(2-mercaptobenzothiazolyl)butane

Imidazolium 2,4-Dihydroxybenzoate

1,4-Bis(4-methoxyphenyl)buta-1,3-diyne

1,4-Bis{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}butane

1,3-Bis(4-tert-butylphenyl)-4-nitrobutan-1-one

1,4-Bis(1h-benzotriazol-1-ylmethyl)benzene Tetrahydrate

N&#8242;-[1-(4-Chlorophenyl)ethylidene]benzohydrazide

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

4-[4-Dimethylamino-1-(4-fluorophenyl)-1-hydroxy-butyl]-3-(hydroxymethyl) Benzonitrile

Exo-4-[(1H-Benzimidazol-2-yl)methyl]-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

(E)-2-[2-(4-fluoro-benzyl-idene)hydrazinocarbon-yl]-n-isopropyl-benzamide.

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

1-(6-Chloropyridin-3-ylmethyl)-1H-benzimidazole

1,4-Bis(benzyloxy)-2-tert-butylbenzene

exo-4-[(1H-Benzimidazol-2-yl)meth-yl]-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

3-(Biphenyl-1-yl)-1-(4-tert-butylphenyl)-3-hydroxyprop-2-en-1-one

1,2,4,5-Tetrakis(bromomethyl)benzene

5,7-Bis(benzyloxy)-4h-benzopyran-4-one

1,4-Bis(benzimidazol-2-yl)butane

1,3-Bis(1h-benzimidazol-2-yl)-2-oxa-propane

1,4-Bis(2-mercaptobenzothiazolyl)butane

Imidazolium 2,4-Dihydroxybenzoate

1,4-Bis(4-methoxyphenyl)buta-1,3-diyne

1,4-Bis{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}butane

1,3-Bis(4-tert-butylphenyl)-4-nitrobutan-1-one

1,4-Bis(1h-benzotriazol-1-ylmethyl)benzene Tetrahydrate

N&amp;#8242;-[1-(4-Chlorophenyl)ethylidene]benzohydrazide

(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

4-[4-Dimethylamino-1-(4-fluorophenyl)-1-hydroxy-butyl]-3-(hydroxymethyl) Benzonitrile

Exo-4-[(1H-Benzimidazol-2-yl)methyl]-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

(E)-2-[2-(4-fluoro-benzyl-idene)hydrazinocarbon-yl]-n-isopropyl-benzamide.

(1<i>S</i>*,4a<i>R</i>*,5<i>S</i>*,6<i>S</i>*,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

1-(6-Chloropyridin-3-ylmethyl)-1H-benzimidazole

1,4-Bis(benzyloxy)-2-tert-butylbenzene

exo-4-[(1H-Benzimidazol-2-yl)meth-yl]-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

3-(Biphenyl-1-yl)-1-(4-tert-butylphenyl)-3-hydroxyprop-2-en-1-one

1,2,4,5-Tetrakis(bromomethyl)benzene

5,7-Bis(benzyloxy)-4h-benzopyran-4-one

N′-[1-(4-Chlorophenyl)ethylidene]benzohydrazide

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one